Nerindocianine for injection

DRUG2 trials

Sponsors

Li-Cor, Inc.

Conditions

Intraoperative Ureter Injury

Phase 1

Dose-escalation Study of a Contrast Agent for Delineation of Urological Anatomy in Minimally Invasive Surgery

CompletedNCT03106038

Li-Cor, Inc.Intraoperative Ureter Injury

Start: 2017-04-26End: 2018-11-19Updated: 2019-11-26

Phase 2

Open-label Study to Evaluate Nerindocianine as a Surgical Aid in Ureter Delineation During Minimally Invasive Surgery

WithdrawnNCT04636567

Li-Cor, Inc.Intraoperative Ureter Injury

Start: 2021-03-31End: 2021-12-31Updated: 2021-07-02